Answers are grounded in this paper and cite their sources.
Discrimination of MN risk integrating Clonal Hematopoiesis Risk Score (CHRS) and proteomics.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: